5 related articles for article (PubMed ID: 38743600)
1. Concentration-QTc and cardiac safety analysis of single and multiple zavegepant nasal spray doses in healthy participants to support approval.
Hughes JH; Bertz R; Bhardwaj R; Donohue MK; Madonia J; Anderson MS; Morris BA; Croop RS; Liu J
CPT Pharmacometrics Syst Pharmacol; 2024 Jun; 13(6):1044-1054. PubMed ID: 38812357
[TBL] [Abstract][Full Text] [Related]
2. Zavegepant for Acute Treatment of Migraine: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
Suresh V; Bardhan M; Dave T; Shamim MA; Suresh D; Satish P; Dhakal B; Bhonsale A; Roy P; Padhi BK; Monteith T
Clin Neuropharmacol; 2024 May-Jun 01; 47(3):72-81. PubMed ID: 38743600
[TBL] [Abstract][Full Text] [Related]
3.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
4.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
5.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
